Rebirth starts without a spare tire

However, there are already channels to treat several infected people with this medicine, and the effect is quite good.

Such a few cases of treatment will not be included in the clinical data, but it can greatly increase the confidence of those investors and relevant parties, and give greater cooperation to the production of this drug.

Even subsequent policies on the epidemic will be adjusted due to the emergence of this drug.

Optimistically, the epidemic can be eradicated within half a year after this special drug is launched.

Policies with and without the epidemic are definitely different and have to be adjusted.

Not only the epidemic prevention needs to be adjusted, but even the economic development plan of the entire country must be adjusted according to such changes.

The impact of the epidemic on economic development is too great.

If it can be eliminated earlier, it should be eliminated earlier.

This also meant that the production and development of this drug could not be done in an ordinary way, it needed to be specially handled, and some licenses were needed.

They are still doing animal experiments, and they are already preparing for human experiments.

There are not so many virus-infected people in China, so we have to go abroad to recruit volunteers.

Tianyuan Group does not have such a channel.

In some aspects, the country must come forward to coordinate.

Chairman He of Xingguo Pharmaceutical once said to Liu Qing half-jokingly and half-seriously:

"Our vaccine market is very good, but if you come up with this special drug, our vaccine project will suffer a lot of losses."

Special medicines can eliminate the virus, and without the virus, naturally no one would be willing to vaccinate.

In this case, it is only natural that the vaccine project suffers.

However, this project has already made its money back. The stock of Xingguo Pharmaceutical has increased several times because of this vaccine project, and the profits it has brought have exceeded tens of billions.

When the special medicine comes out, it can only be said that they can no longer continue to make money, and it cannot be said that they are losing money.

There is still a long time before the specific medicine comes out, and during this time, vaccines will still play an important role.

It also means that you can make a lot of money.

For Chairman He's words, Liu Qing could only smile and say, "Our specific drug is more profitable."

"However, when this specific drug comes out, the epidemic can be wiped out very quickly, and the profit earned is also one-time." Chairman He said.

It's hard to say whether it's the truth or a joke, maybe both.

Liu Qing could only take it as a joke, so she couldn't say much.

Chairman He suddenly asked again: "Mr. Liu, tell me, will those international pharmaceutical giants watch our special medicine go on the market? There are many pharmaceutical groups that eat the epidemic. Do they really hope that the epidemic will be wiped out? "

Chapter 013 The Hope of Eliminating the Epidemic

Regarding Chairman He's worries, Liu Qing actually had some concerns.

This thing is really too important. If we really want to make it out and let other countries know about it, no one can predict what kind of consequences it will have.

There are probably no more than ten countries in the world capable of protecting this achievement.

Maybe even just two or three.

And it should be said that there is only one who can really achieve that no one dares to make a decision.

That one is not China.

This is something that makes people feel very sad but also very helpless.

Liu Qing and the others invest in this new world biopharmaceutical, and there will be no problems in domestic R&D, production and marketing.

But going abroad and competing with those multinational groups is really not an easy task.

People may not allow such drugs to be marketed in their countries.

That harms their interests.

The biggest market is not in your own hands.

To compete for food on other people's territory, one must be prepared to be overturned.

They can only have confidence in the domestic market.

No one in China will prevent them from going public, and no one has the energy to stop them from going public.

But the domestic market is too small, and there are not many infected people at all.

Only relying on the domestic market, there is no way to recover the cost.

In addition, there is another problem. The world is in circulation, and it is useless to cure all the infected people in the country.

Once it is opened up, new patients will be born. If it cannot be opened up, the war against the epidemic will not be considered a success.

"Take your time," Liu Qing can only say, "We can work hard to develop in the third world and see if we can enter their market. As for other things, I hope their government will also think about this world earlier. Back to normal."

"We should make preparations now." Chairman He said.

Domestic pharmaceutical companies do not have much competitiveness in the world, and the orders they can receive are those of generic drugs, which do not have much profit.

The best-selling vaccine abroad is the Xingguo vaccine.

This is already a pleasant surprise.

There are many factors that can lead to such success, not just drugs.

It is really not an easy task to produce a special medicine and get the approval of other countries.

In this regard, none of the domestic enterprises is competitive.

New World Biopharmaceuticals is a new company, and it is really not easy to eat that piece of cake.

It's not that it can be done if there is a curative effect.

Curative effect is not something that you say you have, nor does it mean that others will recognize it if you show some data.

Especially in the case of very few infected people in China, it is difficult to convince people to prove that such a drug is effective.

Much needs to be done.

Now is the time to really prepare.

Liu Qing also agreed with Chairman He's proposal.

Next, those investors held another meeting together to study how to pry open foreign markets.

Another group of people was mobilized to form an overseas public relations team, mainly to study and promote this matter in some countries with severe epidemics.

One of the methods they agreed on was to cooperate with other countries in the clinical trials of this specific drug.

In their country, treating their patients and letting their relevant personnel see the real data can make them believe that the drug is real and effective.

Anyway, there are too few infected people in China, and if we want to carry out Phase III and Phase IV clinical trials, we have to cooperate with other countries.

In the process of cooperation, you might as well give up some benefits so that the partners can also get some benefits, so that they will promote it more vigorously.

For example, give them the agency rights of this special drug in their country.

The Xingguo vaccine project took such a path. At that time, the domestic epidemic was under control and there was no environment for clinical trials. At that time, the project was cooperated with many countries. The project participants provided a lot of convenience and also Got some deals.

Some even got permission to produce the vaccine themselves, but bought the puree from Xingguo Pharmaceuticals.

Of course, this special drug will not be produced by other countries, but some other discounts can be given.

If you want to make all the money, you will often not make any money.

Only by allowing more people to make money can we welcome more partners and make the market bigger.

Those selected countries must have a good relationship with China and have a certain international influence, which is good for the spread of word of mouth.

It is relatively easier to make real achievements in those underdeveloped countries first, so that more people in the world can see the effect of this medicine, and then go to those pharmaceutical groups' sites to grab food.

——Obviously there are special medicines out there, but if you don't introduce them, it will attract many people's doubts.

Moreover, the world is in circulation. There is no special medicine in this country, but other countries have it. People can also go to other countries to take such medicines.

Especially for people in developed countries, it is not a difficult choice to go abroad to cure the disease.

This is not only related to the drug market, but also whether the virus can be completely eliminated from the world and the world can return to normal.

This is an important thing to spend money where it should be spent.

Although New World Biopharmaceuticals is a new company, their registered capital is 300 billion RMB, and this is not an imaginary number, it is a real 300 billion, or more than 40 billion US dollars.

With such a huge sum of money available, many things can be done.

——The activities are carried out in underdeveloped countries, but not in developed countries. The money is absolutely huge.

Drugs have already been developed, and what they lack now is clinical trial data.

Under normal circumstances, the four phases of drug clinical trials take one to five years.

Volunteers needed are also a large number.

As far as the cost of clinical trials in these four stages is concerned, domestic pharmaceutical companies generally cannot bear it, and they simply cannot spend so much money to do this.

This is also an important reason why domestic original research drugs cannot be produced.

That hole is too big.

New World Biopharmaceuticals is not short of money. With a start-up capital of 300 billion, it is doing this kind of clinical trial in an area with a relatively low economic level. It does not matter if it reaches the fourth phase.

What they lack is time.

The sooner it goes public, the earlier the epidemic will be extinguished and the world will return to normal.

Therefore, it is impossible to conduct these four phases of clinical trials according to the longest specification.

Don't say that you can't afford to wait for five years, or even two years.

A year feels like a long time.

This requires a special case.

The fourth stage is post-sale testing of drugs, using more patient data to study whether there are side effects.

In other words, after completing the first three stages of testing, it can be launched for sale.

But this requires a license.

The epidemic is not an ordinary disease. In order to eliminate the epidemic, it is acceptable to the public to license a drug that has been proven to be effective.

In this epidemic, those multinational groups did the same, or the vaccine would not have come out so early.

siluke.com

China has already learned about the effect of this drug, and there is no problem in granting a license.

Not necessarily abroad.

Therefore, the company's cooperation requirements for teams looking for overseas cooperation include one item - after the completion of phase III clinical trials, it can be approved for marketing in the country.

In August, before the factory of Shinsegae Biopharmaceuticals was built, the first phase of clinical trials began.

The first phase of clinical trials is conducted in China, and the specificity of the drug is tested. There are not so many conditions, and the number of people who need to participate in the trial does not need to be too many. It is relatively easy to recruit volunteers.

The first phase of clinical trials has just started, and the recruitment of volunteers for the second phase of clinical trials has started.

Phase I and Phase II clinical trials are all conducted in China, which is not difficult, and there is no need to go abroad to recruit volunteers.

Moreover, the overseas team has only just been established, and we have not even negotiated with foreign partners, let alone recruiting volunteers.

The number of people required for the third phase of clinical trials is relatively large, and there are not so many volunteers recruited in China, so they must go abroad.

And in order to make the data more convincing, volunteers had to be recruited in several countries of different nationalities.

Liu Qing is a layman and doesn't understand these specific things. He just asks about the progress every day, and spends an hour or two to understand how the project is progressing, what difficulties are encountered, and what needs him to do. fixed.

He is the chairman of the newly established company, and important documents must be signed by him.

Although in many cases it was just a cutscene, but during this cutscene time, he also understood some related things.

I can't say it's professional, but the level has reached the point where it won't reveal itself when bragging with laymen.

According to Su Qi's words, that is growth.

In front of insiders, he is a proper outsider.

But in front of laymen, he can act as an expert.